The resource provides recommendations and examples for implementing FSMA Preventive Controls for Human Foods Rule requirements to control known or reasonably foreseeable biological hazards in fresh-cut produce.
The self-affirmed GRAS pathway has supported innovation in the food industry for decades by allowing companies to bring new ingredients to market based on robust scientific evidence. As FDA considers changing this pathway, manufacturers should understand both the criticisms driving the debate and the steps they can take to prepare for potential regulatory change.
Most restaurant brands already collect enough third-party audit data to understand risk better, but the data are usually trapped in a compliance framework. The problem is not a lack of data; it is that the data are organized around checklist completion rather than outbreak causation.
Federally defining UPFs could allow U.S. regulatory agencies to pursue specific policies for the category. The importance of processing versus nutrient content and formulation in causing diet-related chronic diseases, as well as the value of defining UPFs, has been heavily debated.
Importantly, the proposal would not establish a premarket review and approval process for GRAS substances. Companies could still independently conclude that a substance is GRAS and market it while FDA evaluates the notice.
In this bonus episode of Food Safety Matters, we speak to Dr. Mindy Brashears, Under Secretary for Food Safety at the U.S. Department of Agriculture (USDA) and Dr. Justin Ransom, Administrator of USDA's Food Safety and Inspection Service (FSIS), about the future of food safety oversight at USDA. With Dr. Brashears, we discuss FSIS' emerging Salmonella SAFE Strategy and Salmonella Gold Standard, the agency's evolving approach to Listeria control, and the creation of a new scientific advisory panel. Dr. Ransom dives into how FSIS is using connected data, AI, and other emerging technologies to strengthen inspection and identify food safety risks earlier.
The Senate confirmed Erica Schwartz, M.D., J.D., M.P.H. as the new Director of CDC on August 5, making her the agency's first permanent leader in nearly a year. Dr. Schwartz previously served as Deputy Surgeon General during the first Trump administration and as Chief Medical Officer for the U.S. Coast Guard.
Michigan and Ohio recently updated their case counts in a massive Cyclosporacayetanensis outbreak, bringing state-reported totals for all 50 states to at least 21,775 cases. Michigan also reported two deaths tied to the outbreak.
The Global Food Safety Initiative (GFSI) has appointed Elizabeth Andoh-Kesson as Director, marking the next phase of the organization's leadership following her tenure as Interim Director.
FDA has announced the fiscal year (FY) 2027 user fee rates for importers approved to participate in the Voluntary Qualified Importer Program (VQIP) and accreditation and certification bodies interested in participating in the Accredited Third-Party Certification Program (TPP).